Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events
Public ClinicalTrials.gov record NCT02155491. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Global Anticoagulant Registry in the Field Observing Treatment and Outcomes in Patients With Treated Acute Venous Thromboembolic Events in the Real World
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The protocol is a large registry to describe acute, sub-acute and extended duration of anticoagulation management, clinical and economic duration of anticoagulation management, clinical and economic outcomes in patients with treated acute VTE (DVT and PE) in the real-world setting. Main objectives are to clarify the: * treatment related details for acute VTE (either conventional anticoagulation therapy, treatment with a direct oral anti-coagulant or other modalities of treatment) * Rate of early and late symptomatic VTE recurrence * Rate and nature of complications of VTE including post thrombotic syndrome and chronic thromboembolic pulmonary hypertension * Rate of bleeding complications * Rate of all-cause mortality at six months
Study identification
- NCT ID
- NCT02155491
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 10,679 participants
Conditions and interventions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 6, 2014
- Primary completion
- Jan 3, 2020
- Completion
- Sep 29, 2020
- Last update posted
- May 4, 2021
2014 – 2020
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dr Terence Hart | Muscle Shoals | Alabama | 35662 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Venous Thromboembolism trials
Other public records listing Venous Thromboembolism. Sorted by last update posted; newest first. Not a recommendation.
- NCT07350499: Aspiration Thrombectomy Using the Symphony or Prodigy System Recruiting
- NCT07303816: Statins to Prevent Cancer Associated Blood Clots Not yet recruiting
- NCT07399977: Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism Recruiting
- NCT05701917: DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis Recruiting
- NCT05628207: Evaluation of the SCALED (SCaling AcceptabLE cDs) Recruiting
- NCT05881798: Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02155491, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2021 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02155491 live on ClinicalTrials.gov.